KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Common Equity (2016 - 2025)

Cvs Health's Common Equity history spans 17 years, with the latest figure at $75.2 billion for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity changed 0.46% year-over-year to $75.2 billion, compared with a TTM value of $75.2 billion through Dec 2025, changed 0.46%, and an annual FY2025 reading of $75.2 billion, changed 0.46% over the prior year.
  • Common Equity for Q4 2025 was $75.2 billion at Cvs Health, up from $73.1 billion in the prior quarter.
  • The five-year high for Common Equity was $77.6 billion in Q2 2025, with the low at $71.2 billion in Q1 2021.
  • Average Common Equity over 5 years is $74.3 billion, with a median of $74.6 billion recorded in 2021.
  • Year-over-year, Common Equity rose 8.69% in 2021 and then dropped 4.2% in 2022.
  • Tracing CVS's Common Equity over 5 years: stood at $74.8 billion in 2021, then decreased by 4.1% to $71.8 billion in 2022, then grew by 6.78% to $76.6 billion in 2023, then decreased by 1.4% to $75.6 billion in 2024, then dropped by 0.46% to $75.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Common Equity are $75.2 billion (Q4 2025), $73.1 billion (Q3 2025), and $77.6 billion (Q2 2025).